DowpharmaSM Announces Agreement with Pfizer

DowpharmaSM , a business unit of The Dow Chemical Company, has announced that it has entered into an agreement with Pfizer Inc to develop a cell line using Pfēnex Expression TechnologyTM, a Pseudomonas-based technology from Dowpharma.

Under the terms of the agreement, Pfizer will fund efforts at Dowpharma to evaluate the production of a Pfizer therapeutic protein using Pfēnex Expression TechnologyTM, as well as the use of a Dow proprietary solvent extraction technology. Additional financial details of the agreement were not disclosed.

“This agreement demonstrates the interest of the biopharmaceutical industry in producing therapeutic proteins using an expression system that delivers higher yields and process technologies that can reduce the overall cost of goods for biotherapeutics” said Nick Hyde, business director, Dowpharma. “In the cases that we have tested, PfÄ“nex consistently outperforms other commercially available microbial expression systems such as E. coli.”
  
Pfēnex Expression TechnologyTM is built around specially modified strains of Pseudomonas fluorescens bacteria that increase cellular expression while maintaining critical solubility and activity characteristics of recombinantly expressed therapeutic proteins.

“This agreement allows Pfizer, the world’s largest pharmaceutical company, to leverage the resources and technologies of the world's largest chemical company.  We believe our customized solutions and full spectrum of services will continue to meet and exceed the needs of our customers,” said Hyde.

More News:

  • DuPont Challenge Encourages Entries For 2015 Competition

    The DuPont Challenge encourages students to develop a better understanding and passion for STEM by researching and writing an informative essay offering solutions to today’s challenges regarding food, energy, protection and innovation, or a story on a science discovery.

  • SOCMA Hosts 93rd Annual Dinner And Awards Showcase

    The Society of Chemical Manufacturers and Affiliates (SOCMA) is returning to the New York Marriott Marquis Times Square on December 8, 2014, for its 93rd Annual Dinner honoring Performance Improvement Award winners and featuring a Leadership and Business Development Speaker Showcase.

  • Summit Features Bio-Based Tech Startups

    The 6th Next Generation Bio-Based & Sustainable Chemicals Summit, February 3 – February 5, 2015, in New Orleans, LA brings together bio-based tech startups, specialty chemical manufacturers, chemical majors, feedstock providers, financiers and strategic venture capitalists to explore bio-based chemicals.

  • Flint Hills Resources Will Cease Marysville Operations

    Flint Hills Resources plans to close its Marysville, Michigan polypropylene facility.

  • EFCE Seeks Award Nominees

    Award honors outstanding thesis in thermodynamics or transport properties

  • British Safety Regulator Gets New Head

    Executive has worked in both the public and private sectors

  • AkzoNobel Partnership Investigates Waste As Feedstock

    AkzoNobel is part of a major Dutch partnership working with Canada's Enerkem to explore the use of waste streams as a feedstock for chemical production and the development of waste-to-chemicals facilities.

  • Scientist And CorningWare Inventor Stookey Dies

    S. Donald Stookey, credited with inventing CorningWare, died on Tuesday, November 4 at the age of 99.

  • DOE Funds New Gasification Research

    The Department of Energy announced new investments in gasification research.

  • SOCMA Awards Honor EHS&S Improvement

    More than 28 member facilities will receive 2014 Performance Improvement Awards for their outstanding commitment to continuous improvement in environmental, health, safety and security (EHS&S) practices at the Society of Chemical Manufacturers and Affiliates (SOCMA) 93rd Annual Dinner on December 8 in New York.

All news »

What are your comments?

Join the discussion today. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments